Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The present work was designed to study the mechanisms associated with Nurr1 modulation following early life permethrin (PERM) treatment during rat's life span. Here we demonstrate that PERM exposure in rats, at a dose close to No Observed Adverse Effect Level (NOAEL) for 15days during neonatal brain development leads to its accumulation long after exposure. In striatum from adolescent rats we detected an increase in DNA methyltransferases (DNMTs) such as DNMT1, DNMT3a, Tyrosine hydroxylase, monomeric and aggregated α-synuclein protein levels. Adult rats showed enhanced DNMT3b and α-synuclein aggregation compared to the control group, while with aging a significant decrease in all biomarkers studied was observed. No changes in Nurr1 promoter methylation in adolescent, adult and old rats were found. In silico studies showed clear evidence of a strong binding interaction between PERM and its metabolite 3-phenoxybenzoic acid with the nuclear orphan receptor Nurr1. These findings suggest that an additional interference with the dopaminergic neuron pathway could occur in situ during PERM accumulation in brain. Therefore, Nurr1 modulation in early life PERM-treated rats, depends on age-related adaptive responses in animals.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.neuroscience.2016.10.071 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification and Validation of Inverse Agonists for Nuclear Receptor Subfamily 4 Group A Member 2.
ACS Omega
September 2025
Key Laboratory of Liaoning Province for Research on the Pathogenic Mechanisms of Neurological Diseases, The First Affiliated Hospital, Dalian Medical University, 116021 Dalian, China.
Former studies indicate that nuclear receptor subfamily 4 group A member 2 (Nurr1, NR4A2), a transcription factor, is regarded as a potential therapeutic target for central nervous system diseases, and many studies have focused on the development and optimization of agonists of Nurr1. Recent studies have shown that Nurr1 is upregulated in many other diseases. However, there is still a lack of effective inverse Nurr1 agonists as a therapeutic strategy or as pharmacological tools to counteract the receptor's inherent activity.
View Article and Find Full Text PDFSaikosaponin A, a bioactive compound from Bupleuri radix, protects dopaminergic neurons and correlates with NURR1 expression in 6-hydroxydopamine-injected hemi-parkinsonian mouse model.
Pharmacol Rep
August 2025
Department of Oriental Pharmaceutical Science and Kyung Hee East-West Pharmaceutical Research Institute, College of Pharmacy, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea.
Background: Parkinson's disease (PD) is characterized by progressive dopaminergic neuronal loss, and current treatments are limited by their inability to prevent neurodegeneration. NURR1, a crucial transcription factor for dopaminergic neuron survival, has emerged as a promising therapeutic target. This study investigated whether Saikosaponin A (SSA), a bioactive compound from Bupleuri radix, exhibits neuroprotective effects through NURR1-mediated mechanisms in 6-hydroxydopamine (6-OHDA)-induced PD models.
View Article and Find Full Text PDFCarboxylic Acid Bioisosteres Boost Nurr1 Agonist Selectivity.
J Med Chem
August 2025
Department of Pharmacy, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Nuclear receptor related 1 (Nurr1) is a neuronal ligand-activated transcription factor implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease and multiple sclerosis, which has fueled the development of Nurr1 modulators. Among them, the clinically studied dihydroorotate dehydrogenase (DHODH) inhibitor vidofludimus was found to exhibit strong Nurr1 agonism. Here, we aimed to establish a vidofludimus-derived Nurr1 agonist lacking DHODH inhibitor potency as a tool.
View Article and Find Full Text PDFBerberine mitigates colitis-associated neuroinflammation and anxiety through modulation of the AMPK/NURR1 pathway.
Naunyn Schmiedebergs Arch Pharmacol
June 2025
Clinical Pharmacology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Inflammatory bowel disease (IBD) is linked to psychiatric issues like anxiety and depression. Berberine (BER), a natural compound with anti-inflammatory and antioxidant characteristics, shows promise in managing IBD. However, its effects on inflammation-induced anxiety and the underlying mechanisms remain imprecise.
View Article and Find Full Text PDFPhysics of Protein Aggregation in Normal and Accelerated Brain Aging.
Bioessays
August 2025
Department of Translational Neuroscience and the Muhammad Ali Parkinson Center, Barrow Neurological Institute, Phoenix, Arizona, USA.
Protein aggregation is a normal response to age-related exposures. According to the thermodynamic hypothesis of protein folding, soluble proteins precipitate into amyloids (pathology) under supersaturated conditions through a process similar to crystallization. This soluble-to-insoluble phase transition occurs via nucleation and may be catalyzed by ectopic surfaces such as lipid nanoparticles, microbes, or chemical pollutants.
View Article and Find Full Text PDF